ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 276

Effectiveness of Screening by Nurse with Predetermined Questionnaire on Infections Before Administration of Intravenous Biologics in Patients with Rheumatoid Arthritis

Sayaka Furukawa1, Sho Fukui 1, Sakura Tamaki 2, Tomoko Nakasone 3 and Masato Okada 4, 1St.Luke's International Hospital, Chuo-ku, Tokyo, Japan, 2St. Luke's International Hospital, Chuo-ku, Japan, 3St. Luke's International Hospital, Chuo-ku, Tokyo, Japan, 4St. Luke's International Hospital, Tokyo, Japan

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Biologic drugs, infection and Japanese, nursing roles, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Health Services Research Poster I – ACR/ARP

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Biologics are widely used as treatment for rheumatoid arthritis (RA), and pre-administration screening of active infection is imperative for the safety use. There is no standardized way in the assessment of infection by nurse and it is often difficult and time-consuming. We implemented new method in which nurses systematically use pre-determined questionnaires on infections before doctors examine the patients for confirmation. Our aim of this study is to reveal effectiveness of this new method of assessments.

Methods: We retrospectively reviewed charts of patients with RA who received intravenous biologics at St. Luke’s International Hospital, Tokyo, Japan from January 2016 to April 2019. We investigated basic demographics, kinds of biologics and other treatments, underlying diseases, incidence of serious infection(SI), and opportunistic infections. SI was defined as bacterial infections requiring intravenous antibiotics, hospitalization, or resulting in death. We calculated the number of scheduled administrations and evaluated results of screening by nurse and doctor’s assessment. We compared the number of infections in the new method with those in conventional one. Univariate analysis and Chi-square test were performed. We also asked nurses for their feeling about this new screening method with questionnaire.

Results: We identified 271 cases in total. There are 143 and 128 patients who received intravenous biologics from January 2016 to August 2017 with conventional assessment and from September 2017 to April 2019 with new-style assessment. There are no significant differences in the baseline characteristics and the number of SI between new and conventional methods (7.7% vs 8.6%; p= 0.827)(Table1). New screening method showed high sensitivity (0.98) and specificity (0.89) and there was just 1 case in which doctors postponed biologics even the patient was assessed not to have active infections by nurse (Fig 1). Eighty eight % of nurses answered new method is easy and efficient, and 30% answered time-efficient. (Figure2)

Conclusion: Systematical screening by nurse with pre-determined questionnaires is effective as a screening with high sensitivity and nurses are satisfied with its convenience and time-efficiency. Doctors can carefully see cases in which infections are suspected by nurse. Our new-method of pre-administration assessments can contribute to time-efficient practice without any increasing risk of SI.


Disclosure: S. Furukawa, None; S. Fukui, None; S. Tamaki, None; T. Nakasone, None; M. Okada, None.

To cite this abstract in AMA style:

Furukawa S, Fukui S, Tamaki S, Nakasone T, Okada M. Effectiveness of Screening by Nurse with Predetermined Questionnaire on Infections Before Administration of Intravenous Biologics in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/effectiveness-of-screening-by-nurse-with-predetermined-questionnaire-on-infections-before-administration-of-intravenous-biologics-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effectiveness-of-screening-by-nurse-with-predetermined-questionnaire-on-infections-before-administration-of-intravenous-biologics-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology